|Institution:||Nottingham Trent University|
|Line 1:||School of Science and Technology|
|Line 2:||Nottingham Trent University|
|Line 3:||Nottingham Trent University|
We’re now offering over 50 fully-funded PhD studentships for UK, EU or international students in our core subject areas or key research themes, including cancer research. Apply Now to join the next generation of research leaders.
Cancer Biology, Immunology and Therapeutics conducts fundamental and translational research into a range of cancers, including breast, colorectal, pancreatic, liver, prostate, skin (malignant melanoma), brain (glioblastoma multiforme) and ovarian, as well as acute leukaemia and other haematological malignancies and on novel therapeutic options.
Research focuses on the unmet clinical needs via pre-clinical and clinical research into the identification of biomarkers for diagnosis, disease prediction and therapeutic response. We are also developing peptide and DNA-based vaccines and cell-based immunotherapeutic strategies for the treatment of aggressive disease and new approaches for modifying the immunology of the tumour microenvironment in order to improve therapeutic outcomes . These studies are interrogating important molecular pathways and the key events associated with malignancy using state-of-the-art analytical platforms in the John van Geest Cancer Research Centre such as cell cytometry, mass spectrometry and gene expression arrays, and are supported by advanced bioinformatics and computational capabilities.
Closing date for applications: 25 February 2019 at 5 pm UK Time
Start date: 1 October 2019 or 5 January 2020